Minority Views
[To accompany H.R. 1158]
The Committee on Energy and Commerce, to whom was referred
the bill (H.R. 1158) to amend the Toxic Substances Control Act
with respect to new critical energy resources, and for other
purposes, having considered the same, reports favorably thereon
without amendment and recommends that the bill do pass.
CONTENTS
Page
Purpose and Summary.............................................. 2
Background and Need for Legislation.............................. 2
Committee Action................................................. 4
Committee Votes.................................................. 5
Oversight Findings and Recommendations........................... 9
New Budget Authority, Entitlement Authority, and Tax Expenditures 9
Congressional Budget Office Estimate............................. 9
Federal Mandates Statement....................................... 9
Statement of General Performance Goals and Objectives............ 9
Duplication of Federal Programs.................................. 9
Related Committee and Subcommittee Hearings...................... 9
Committee Cost Estimate.......................................... 10
Earmark, Limited Tax Benefits, and Limited Tariff Benefits....... 10
Advisory Committee Statement..................................... 10
Applicability to Legislative Branch.............................. 10
Section-by-Section Analysis of the Legislation................... 10
Changes in Existing Law Made by the Bill, as Reported............ 12
Minority Views................................................... 22
Purpose and Summary
To amend the Toxic Substances Control Act (TSCA) with
respect to critical energy resources, to prevent delays on the
U.S. Environmental Protection Agency (EPA) deciding whether a
critical energy resource presents an unreasonable risk, and to
prohibit EPA from pre-emptively attempting to suspend reviews
of future technology.
Background and Need for Legislation
TSCA is unique among Federal statutes; it gives the
Environmental Protection Agency (EPA) sweeping authority to
regulate the manufacture, processing, distribution in commerce,
use and disposal of ``chemical substances'', mixtures of
``chemical substances'', and articles containing ``chemical
substances'' before they enter commerce and once, they are in
it. A TSCA ``chemical substance'' is very broadly defined--with
a few exceptions, it is ``any organic or inorganic substance of
a particular molecular identity''\1\
---------------------------------------------------------------------------
\1\ TSCA section 3(2)(A)--15 U.S.C. 2602(2)(A).
---------------------------------------------------------------------------
Because of this, TSCA directly impacts American innovation
for products that directly improve the standard of living for
our families and contribute to our global competitiveness.
Disjointed or poor implementation of TSCA will not just affect
innovation in this country but discourage investment and lead
to fewer products that are cleaner and greener.\2\ To guard
against a bad outcome, TSCA Section 2 states two things:
---------------------------------------------------------------------------
\2\ https://docs.house.gov/meetings/IF/IF18/20130613/100980/HMTG-
113-IF18-Wstate-AuerC-20130613.pdf.
---------------------------------------------------------------------------
It is U.S. policy that authority over
chemicals should not unduly impede nor create
unnecessary economic barriers to technological
innovation.
Congress intends TSCA be implemented in ``a
reasonable and prudent manner'', and EPA must consider
``the environmental, economic, and social impact of any
action the Administrator takes or proposes to take''.
As mentioned above, TSCA gives EPA authority to regulate
chemicals before they enter the market. TSCA section 5, in a
few key areas, has remain unchanged since its 1976 enactment.
First, it requires the manufacturer of a new chemical
substance or the manufacturer or processor of a new use of a
commercialized chemical substance to notify EPA--at least 90-
days in advance--of their intent to commercially manufacture.
Second, upon receiving this notice, EPA has the opportunity
to review information about the new chemical or new use and, if
necessary, take action to limit or prevent an unreasonable risk
to health that EPA sees presented by the commercial
introduction of the new chemical substance or new use.
Third, if EPA needs more time to review the notice, EPA can
delay the notice's submitter from commercial production for up
to another 90 days (180 in total).\3\ Moreover, if EPA needs
more data to make its determination about an unreasonable risk,
EPA can order the company to submit more information--which
would stop the statutory clock until the information is given
to EPA.\4\
---------------------------------------------------------------------------
\3\ TSCA section 5(c)--15 U.S.C. 2604(c).
\4\ TSCA section 5(b)--15 U.S.C. 2604(b).
---------------------------------------------------------------------------
Fourth, there is a regulatory option for a notice submitter
to voluntarily withdraw or suspend the clock on their notice
if--in talking to EPA--the company learns EPA was leaning
towards declaring an unreasonable risk that would limit or
prevent their new chemical or new use from going to market.\5\
---------------------------------------------------------------------------
\5\Section 720.75(b) of title 40, Code of Federal Regulations
---------------------------------------------------------------------------
In May and June of 2016, Congress passed, and the President
signed into law the Frank R. Lautenberg Chemical Safety for the
21st Century Act (Public Law 114-182), which amended TSCA
section 5 provisions related to what happens after the 180-day
period expired and EPA had not made a determination on notice
concerning a new chemical or new use of an existing
chemical.\6\ Prior to the June 2016 amendments, if EPA, within
90 days--but no more than 180 days--made no determination of
risk or asked for more information to conduct a review on the
notice, the manufacturer was free to produce the new substance
or new use. After enactment of the Frank R. Lautenberg Chemical
Safety for the 21st Century Act, while the 90 day and 180-day
deadlines were maintained to avoid EPA apathy towards American
manufacturers who needed predictability from the process, to
provide tangible evidence of EPA reviews, no new chemical
substance or new use could enter commerce until EPA had
determined whether it presented a newly defined ``unreasonable
risk,'' and regulated that risk.\7\ Also, if EPA missed the
review deadline, it had to refund the entirety of the user fees
paid by the applicant. Despite the deadline mandate and the
refund requirement, the frequency of decisions has dramatically
dropped, and EPA has not returned any user fees for missing a
statutory deadline because all those applicants voluntarily
suspended or withdrew their notices.
---------------------------------------------------------------------------
\6\https://www.congress.gov/bill/114th-congress/house-bill/2576.
\7\Section 5 of Public Law 114-182.
---------------------------------------------------------------------------
TSCA is not the only Federal law with an ``unreasonable
risk'' standard, but it is the only one to limit considerations
under it. Prior to June 2016 and in other laws, ``unreasonable
risk'' was considered an evaluation of a chemical's risk to
determine if the risk was a reasonable one based upon the
utility of the product, or the utility of the aspect of the
product that causes the risk, the level of exposure to the
risk, the nature and severity of the hazard presented, and the
likelihood of resulting serious injury or death. The
unreasonable risk analysis also evaluates the state of
manufacture, the availability of alternative designs or
products, and the feasibility of eliminating the risk or
creating greater ones by shifting to those alternatives. For
instance, the Federal Insecticide, Fungicide, and Rodenticide
Act (FIFRA) defines ``unreasonable adverse effects to the
environment'' to include an ``unreasonable risks to [persons]
or the environment taking into account the economic, social,
and environmental costs and benefits of the use of any
pesticide''.\8\
---------------------------------------------------------------------------
\8\FIFRA section 2(bb)(1)--7 U.S.C. 136(bb)(1).
---------------------------------------------------------------------------
The 2016 amendments changed the definition of
``unreasonable risk'' to preclude EPA from considering ``costs
or other non-risk factors.'' While the intent was to eliminate
the consideration of compliance and enforcement costs, EPA's
practice, however, has been to misinterpret this language in
two significant ways that ignore risk factors: it interprets
``unreasonable'' as an invisible modifier of ``risk'' (meaning
it is not considering certain risks as reasonable) and EPA's
practice limits the acceptable level of reasonable risk while
discounting risk reduction benefits--including the health and
environmental benefits that may be provided by the new
chemical. In other words, a ``safer'' chemical is unacceptable,
only ``safe'' chemicals (i.e., ones without any hazards
identified by EPA) are permissible without a regulation.
The results of the 2016 law have been striking in another
way. EPA's reviews of applications for new chemicals and new
uses of existing chemicals have gotten increasing slower;
exacerbating the backlog of innovative technologies that must
wait for decisions--only 85 chemicals received a final
determination in 2021, down from 663 in 2011.\9\ The average
review time for these chemicals since 2016 has also increased
to 432 days.\10\ Since 2016, annual submissions for new
chemicals and new uses of existing chemicals fell 65 percent
from an average of 270 to 178 in 2020.\11\ EPA was on pace to
only receive 192 new chemical notices in, post-pandemic,
2022.\12\ This decline means losses in US-made products,
including those to reduce greenhouse gases, reduce water
consumption, and make products more durable and biodegradable.
---------------------------------------------------------------------------
\9\Op. Cit.
\10\Op. Cit. Captured March 2, 2023.
\11\https://chemicalinnovations.org/.
\12\Ibid.
---------------------------------------------------------------------------
Compounding the meager output of decisions and diminished
number of new notices being submitted is a growing backlog of
notices. According to EPA's website, there were 405 pre-
manufacturing notices (PMNs) under review at EPA as of February
1, 2023. Of this number, 341 of these PMNs remain at EPA
awaiting a decision even though the statutory deadline has
expired. Data from the EPA's website also demonstrates that
this backlog has increased by 40 percent in the last 2 years.
Most concerning, 51 percent of the legal determination backlog
has been in limbo for more than 1 year--with 60 percent of that
group's wait exceeding 2 years. In addition, the Government
Accountability Office recently noted EPA's been getting worse
with time, failing to meet the legal deadline for determination
100 percent of the time last year. This occurred while EPA's
overall budget has grown 10 percent over the last few years--
from $9.24 billion in Fiscal Year 2021\13\ to $10.14 billion in
Fiscal Year 2023\14\--plus, add in $1.67 billion in
supplemental funding,\15\ another $25.27 billion under the
Infrastructure Investment and Jobs Act,\16\ and $14.46 billion
for the Inflation Reduction Act.\17\
---------------------------------------------------------------------------
\13\P.L. 116-260.
\14\P.L. 117-328, Division G.
\15\P.L. 117-328, Division N.
\16\P.L. 117-58.
\17\P.L. 117-169.
---------------------------------------------------------------------------
Committee Action
On February 7, 2023, the Subcommittees on Energy, Climate,
and Grid Security and Environment, Manufacturing, and Critical
Materials held a joint hearing entitled, ``Unleashing American
Energy, Lowering Energy Costs, and Strengthening Supply
Chains,'' on 17 pieces of legislation, including H.R. 1158. The
Subcommittees received testimony from:
The Honorable Mark Menezes, Former United
States Deputy Secretary of Energy, Department of
Energy.
The Honorable Bernard McNamee, Former
Commissioner, Federal Energy Regulatory Commission.
Jeffrey Eshelman, II, President and Chief
Executive Officer, Independent Petroleum Association of
America.
Katie Sweeney, Executive Vice President and
Chief Operating Officer, National Mining Association.
Raul Garcia, Legislative Director for
Healthy Communities, Earthjustice; and
Tyson Slocum, Director of the Energy
Program, Public Citizen.
On February 28, 2023, the Subcommittee on Environment,
Manufacturing and Critical Materials met in open markup session
and forwarded H.R. 1158, without amendment, to the full
Committee by a record vote of 13 yeas and 6 nays. On March 9,
2023, the full Committee on Energy and Commerce met in open
markup session and ordered H.R. 1158, without amendment,
favorably reported to the House by a record vote of 27 yeas and
21 nays.
Committee Votes
Clause 3(b) of rule XIII requires the Committee to list the
record votes on the motion to report legislation and amendments
thereto. The following reflects the record votes taken during
the Committee consideration:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
Oversight Findings and Recommendations
Pursuant to clause 2(b)(1) of rule X and clause 3(c)(1) of
rule XIII, the Committee held hearings and made findings that
are reflected in this report.
New Budget Authority, Entitlement Authority, and Tax Expenditures
Pursuant to clause 3(c)(2) of rule XIII, the Committee
finds that H.R. 1158 would result in no new or increased budget
authority, entitlement authority, or tax expenditures or
revenues.
Congressional Budget Office Estimate
Pursuant to clause 3(c)(3) of rule XIII, at the time this
report was filed, the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974 was not available.
Federal Mandates Statement
The Committee adopts as its own the estimate of Federal
mandates prepared by the Director of the Congressional Budget
Office pursuant to section 423 of the Unfunded Mandates Reform
Act.
Statement of General Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII, the general
performance goal or objective of this legislation is to
increase American energy production and restore energy
leadership by amending the Toxic Substances Control Act with
respect to critical energy resources, to prevent delays on the
Environmental Protection Agency deciding whether a critical
energy resource presents an unreasonable risk, and to prohibit
EPA from pre-emptively attempting to suspend reviews of future
technology.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII, no provision of
H.R. 1158 is known to be duplicative of another Federal
program, including any program that was included in a report to
Congress pursuant to section 21 of Public Law 111-139 or the
most recent Catalog of Federal Domestic Assistance.
Related Committee and Subcommittee Hearings
Pursuant to clause 3(c)(6) of rule XIII,
(1) the following hearings were used to develop or consider
H.R. 1158:
A January 31, 2023, hearing by the Committee
on Energy and Commerce entitled, ``American Energy
Expansion: Strengthening Economic, Environmental, and
National Security.''
A February 7, 2023, joint hearing by the
Subcommittees on Energy, Climate, and Grid Security and
Environment, Manufacturing, and Critical Materials
entitled, ``Unleashing American Energy, Lowering Energy
Costs, and Strengthening Supply Chains''.
(2) The following related hearings were held:
An October 27, 2021, hearing by the
Subcommittee on Environment and Climate Change
entitled, ``TSCA and Public Health: Fulfilling the
Promise of the Lautenberg Act.''
A May 17, 2022, hearing by the Subcommittee
on Environment and Climate Change entitled, ``The
Fiscal Year 2023 EPA Budget.''
Committee Cost Estimate
Pursuant to clause 3(d)(1) of rule XIII, the Committee
adopts as its own the cost estimate prepared by the Director of
the Congressional Budget Office pursuant to section 402 of the
Congressional Budget Act of 1974. At the time this report was
filed, the estimate was not available.
Earmark, Limited Tax Benefits, and Limited Tariff Benefits
Pursuant to clause 9(e), 9(f), and 9(g) of rule XXI, the
Committee finds that H.R. 1158 contains no earmarks, limited
tax benefits, or limited tariff benefits.
Advisory Committee Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Section-by-Section Analysis of the Legislation
Section 1
Section 1 provides a short title of ``Elimination of Future
Technology Delays Act of 2023.''
Section 2
Section 2 creates amendments to the end of TSCA section
5(a) to create a different review regime for critical energy
resources.
First, section 2, using the FIFRA standard for
``unreasonable adverse effects to the environment,'' requires
EPA to consider ``economic, societal, and environmental costs
and benefits'' when deciding if an unreasonable risk is present
by a new chemical or new use of an existing chemical that is a
critical energy resource. These are legitimate risk factors in
weighing both whether an ``unreasonable risk'' is present for
deciding whether and, if so how, to regulate a chemical
substance.
Second, section 2, recognizing the increasing backlog and
the deleterious impact to innovation, returns section 5 to its
pre-2016 status and puts a hard trigger on EPA to meet the
statutory deadlines--90 days, but in no case, no more than 180
days--to decide on the risks presented by a new critical energy
resource. The bill does not undercut EPA's ability to request
additional information if it is needed to do the evaluation--
which allows the clock to be stopped until the information is
given to EPA. With millions of dollars in investment on the
line and China and others offering the alternative venues for
manufacturing, EPA cannot foot-drag and it cannot make excuses.
If EPA does not decide in this time--and does not ask for more
information to make one--the new critical energy resource can
go to commercial manufacture. Importantly, the Committee
intends that when EPA does not meet its statutory deadlines
that it is not allowed to claw back regulation of chemicals in
the marketplace. For this reason, the language requires EPA
only undertake efforts to regulate commercially produced
chemical substance under TSCA section 6.
The Committee understands that some critics will be
surprised this bill is reversing a few provisions of the 2016
amendments only six years after their enactment. The Committee
believes that while the situation appears to be deteriorating,
if Congress cannot take action to address critical materials
that are vulnerable to disruption, what will it take for
Congress to correct this entire matter? The Committee notes
that the overall thrust of the 2016 amendments remain intact in
this legislation regarding new chemicals and new uses.
Particularly, this bill: does not prevent the EPA from deciding
on new chemicals and new uses of a chemical, does not force EPA
to approve chemicals regardless of their toxicity, does not
change the definition of a ``potentially exposed or susceptible
population'', EPA still maintains very muscular authority to
compel new information to assess a chemical, and EPA must still
assess for the existence of and adequately control an
unreasonable risk to a potentially exposed or susceptible
population identified by EPA.
Third, under section 2, a manufacturer of critical energy
resource that is a new chemical substance or new use of a
chemical substance may only receive a refund of their user fee
from EPA if that manufacturer does not begin commercial
manufacture of the critical energy resource and continues to
wait for a risk determination from EPA. The Committee
acknowledges that EPA likely performed some work on a notice
even when a decision is not rendered timely and does not
believe the Agency should be financially punished for that work
nor made to take additional steps to prorate the fee.
Fourth, section 2, in furtherance of the Committee's
insistence on adherence to statutory deadliners, prevents EPA
from suggesting to or requesting of a notice submitter that
they, pursuant to existing regulations, voluntarily suspend or
withdraw their pre-manufacturing notice unless EPA has first
reviewed the notice, made an initial determination on the
notice, and shares that initial determination with the
manufacturer. The Committee notes that use of the term
``preliminary review'' is not intended to create a formal step
or process but rather to capture that EPA has paid enough
attention to the notice to make an initial, reasonable, and
informed assessment of the chemical notice that was submitted
and the potential risks that might be present.
Finally, section 2 adds a definition to proposed TSCA
section 5(a)(6) for ``critical energy resource.'' It states
that a ``critical energy resource'' is any energy resource
that, as determined by the Secretary of Energy, is essential to
the energy sector and energy systems of the United States and
whose supply chain is vulnerable to disruption. The Committee
intends this definition to be interpreted broadly and points to
the word ``any'' as proof of this desire. This designation is
not limited to the use of one kind of fuel but instead includes
all types of fuels that are important to our nation's energy
sector and system and that might be vulnerable to disruption.
Moreover, while this designation is purposely the domain of the
Secretary of Energy--not the Secretary of Interior or EPA--who
has been given statutory responsibility of and care for the
energy sector and systems of the United States, the
determinations about whether an unreasonable risk exists under
TSCA are the domain of EPA. The Committee expects the Secretary
of Energy to work cooperatively and expeditiously with EPA to
determine whether a notice under TSCA section 5(a) would
qualify as a critical energy resource for the purposes of this
proposed amendment.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (new matter is
printed in italics and existing law in which no change is
proposed is shown in roman):
TOXIC SUBSTANCES CONTROL ACT
TITLE I--CONTROL OF TOXIC SUBSTANCES
* * * * * * *
SEC. 5. MANUFACTURING AND PROCESSING NOTICES.
(a) In General.--(1)(A) Except as provided in subparagraph
(B) of this paragraph and subsection (h), no person may--
(i) manufacture a new chemical substance on or after
the 30th day after the date on which the Administrator
first publishes the list required by section 8(b), or
(ii) manufacture or process any chemical substance
for a use which the Administrator has determined, in
accordance with paragraph (2), is a significant new
use.
(B) A person may take the actions described in
subparagraph (A) if--
(i) such person submits to the Administrator,
at least 90 days before such manufacture or
processing, a notice, in accordance with
subsection (d), of such person's intention to
manufacture or process such substance and such
person complies with any applicable requirement
of, or imposed pursuant to, subsection (b),
(e), or (f); and
(ii) the Administrator--
(I) conducts a review of the notice;
and
(II) makes a determination under
subparagraph (A), (B), or (C) of
paragraph (3) and takes the actions
required in association with that
determination under such subparagraph
within the applicable review period.
(2) A determination by the Administrator that a use of a
chemical substance is a significant new use with respect to
which notification is required under paragraph (1) shall be
made by a rule promulgated after a consideration of all
relevant factors, including--
(A) the projected volume of manufacturing and
processing of a chemical substance,
(B) the extent to which a use changes the type or
form of exposure of human beings or the environment to
a chemical substance,
(C) the extent to which a use increases the magnitude
and duration of exposure of human beings or the
environment to a chemical substance, and
(D) the reasonably anticipated manner and methods of
manufacturing, processing, distribution in commerce,
and disposal of a chemical substance.
(3) Review and determination.--Within the applicable
review period, subject to section 18, the Administrator
shall review such notice and determine--
(A) that the relevant chemical substance or
significant new use presents an unreasonable
risk of injury to health or the environment,
without consideration of costs or other nonrisk
factors, including an unreasonable risk to a
potentially exposed or susceptible
subpopulation identified as relevant by the
Administrator under the conditions of use, in
which case the Administrator shall take the
actions required under subsection (f);
(B) that--
(i) the information available to the
Administrator is insufficient to permit
a reasoned evaluation of the health and
environmental effects of the relevant
chemical substance or significant new
use; or
(ii)(I) in the absence of sufficient
information to permit the Administrator
to make such an evaluation, the
manufacture, processing, distribution
in commerce, use, or disposal of such
substance, or any combination of such
activities, may present an unreasonable
risk of injury to health or the
environment, without consideration of
costs or other nonrisk factors,
including an unreasonable risk to a
potentially exposed or susceptible
subpopulation identified as relevant by
the Administrator; or
(II) such substance is or will be
produced in substantial quantities, and
such substance either enters or may
reasonably be anticipated to enter the
environment in substantial quantities
or there is or may be significant or
substantial human exposure to the
substance,
in which case the Administrator shall take the
actions required under subsection (e); or
(C) that the relevant chemical substance or
significant new use is not likely to present an
unreasonable risk of injury to health or the
environment, without consideration of costs or
other nonrisk factors, including an
unreasonable risk to a potentially exposed or
susceptible subpopulation identified as
relevant by the Administrator under the
conditions of use, in which case the submitter
of the notice may commence manufacture of the
chemical substance or manufacture or processing
for a significant new use.
(4) Failure to render determination.--
(A) Failure to render determination.--If the
Administrator fails to make a determination on
a notice under paragraph (3) by the end of the
applicable review period and the notice has not
been withdrawn by the submitter, the
Administrator shall refund to the submitter all
applicable fees charged to the submitter for
review of the notice pursuant to section 26(b),
and the Administrator shall not be relieved of
any requirement to make such determination.
(B) Limitations.--(i) A refund of applicable
fees under subparagraph (A) shall not be made
if the Administrator certifies that the
submitter has not provided information required
under subsection (b) or has otherwise unduly
delayed the process such that the Administrator
is unable to render a determination within the
applicable review period.
(ii) A failure of the Administrator to render
a decision shall not be deemed to constitute a
withdrawal of the notice.
(iii) Nothing in this paragraph shall be
construed as relieving the Administrator or the
submitter of the notice from any requirement of
this section.
(5) Article consideration.--The Administrator may
require notification under this section for the import
or processing of a chemical substance as part of an
article or category of articles under paragraph
(1)(A)(ii) if the Administrator makes an affirmative
finding in a rule under paragraph (2) that the
reasonable potential for exposure to the chemical
substance through the article or category of articles
subject to the rule justifies notification.
(6) Critical energy resources.--
(A) Standard.--For purposes of a
determination under paragraph (3) with respect
to a chemical substance that is a critical
energy resource, the Administrator shall take
into consideration economic, societal, and
environmental costs and benefits,
notwithstanding any requirement of this section
to not take such factors into consideration.
(B) Failure to render determination.--
(i) Actions authorized.--If, with
respect to a chemical substance that is
a critical energy resource, the
Administrator fails to make a
determination on a notice under
paragraph (3) by the end of the
applicable review period and the notice
has not been withdrawn by the
submitter, the submitter may take the
actions described in paragraph (1)(A)
with respect to the chemical substance,
and the Administrator shall be relieved
of any requirement to make such
determination.
(ii) Non-duplication.--A refund of
applicable fees under paragraph (4)(A)
shall not be made if a submitter takes
an action described in paragraph (1)(A)
under this subparagraph.
(C) Prerequisite for suggestion of withdrawal
or suspension.--The Administrator may not
suggest to, or request of, a submitter of a
notice under this subsection for a chemical
substance that is a critical energy resource
that such submitter withdraw such notice, or
request a suspension of the running of the
applicable review period with respect to such
notice, unless
Minority Views
H.R. 1158, the ``Elimination of Future Technology Delays
Act,'' amends Section 5 of the Toxic Substances Control Act
(TSCA) related to new chemical reviews--changes that would put
human health and the environment at risk. The legislation would
reverse and eliminate fundamental safety protections enacted in
the bipartisan TSCA reform law, the Frank R. Lautenberg
Chemical Safety for the 21st Century Act (Lautenberg Act),\1\
in an attempt to expedite review of chemicals classified as
``critical energy resources.'' The majority report
mischaracterizes the need for this legislation and its effects.
---------------------------------------------------------------------------
\1\Pub. L. No. 114-182 (2016).
---------------------------------------------------------------------------
Background
TSCA, which originally passed in 1976, is the nation's
chemical safety law.\2\ Under TSCA, the Environmental
Protection Agency (EPA) is responsible for identifying,
testing, and regulating chemical substances in U.S. commerce
whose manufacture, processing, distribution in commerce, use,
and disposal present or will present an unreasonable risk of
injury to health or the environment. The original 1976 law
failed to protect public health, allowing a majority of
chemicals to enter commerce without complete review or
consideration of safety, exposing workers and families to toxic
chemicals.
---------------------------------------------------------------------------
\2\15 U.S.C. Sec. 2601 et seq. (1976).
---------------------------------------------------------------------------
In 2016, President Obama signed into law the Lautenberg
Act, bipartisan legislation that amended Title I of TSCA. Among
the amendments, the Lautenberg Act overhauled Section 5 by
adding protections that require EPA to identify and manage
risks associated with each new chemical before it is
manufactured or used.
SUMMARY OF H.R. 1158
H.R. 1158 amends Section 5(a) of TSCA to create a new
regulatory pathway for chemicals designated as ``critical
energy resources'', circumventing key public health
protections. The new Section 5(a)(6)(A), as proposed in H.R.
1158, would require EPA to consider costs and other non-risk
factors when making a determination for any chemical deemed a
``critical energy resource.'' Currently, TSCA explicitly
prohibits EPA from considering costs and other non-risk factors
when evaluating whether the chemical substance poses an
unreasonable risk. EPA may only consider such factors when
deciding how to manage any risks it identifies.
By injecting non-risk factors into safety determinations
based solely on risks to health or the environment, the
majority is prioritizing economic considerations of chemical
companies over public health. Also, adding non-risk factors
would require EPA to conduct economic analyses and assessments
of indirect benefits, which would add to the review time and
thereby defeat one of the stated purposes of the legislation.
Section 5(a)(6)(B) allows a company to commence the
manufacture or use of a new chemical designated a ``critical
energy resource'' within 90 days in the absence of a
determination by EPA. This reverses one of the core reforms in
the Lautenberg Act. Previously, EPA issued risk determinations
for approximately 20 percent of new chemical submissions,
allowing 80 percent of chemicals to go to market without
further review. The original 1976 law failed to protect
families and communities from exposure to toxic chemicals in
everything from household goods to releases from nearby
factories. Congress addressed this fundamental flaw in 2016 by
requiring EPA to review each new chemical, make a final
determination, and take any needed regulatory action prior to
and as a condition of a company's commencement of manufacture
or use of that chemical. With H.R. 1158, the majority is
effectively reversing course and providing a pathway for
potentially toxic chemicals to enter the market undetected.
This policy is ill-conceived and dangerous, needlessly exposing
children, families, and fenceline communities to harm.
Section 5(a)(6)(C) would create an intermediary step of
conducting a ``preliminary review'' of the new chemical
substance and sharing it with the submitter. Adding these
additional steps would lead to multiple iterations of
assessment work by EPA and increase the amount of time it takes
for EPA to complete its review and risk management.
Section 5(a)(6)(D) broadly defines ``critical energy
resources'' as a chemical, determined by the Secretary of
Energy, to be essential to the energy sector and vulnerable to
supply chain disruption. This definition could apply to
virtually any chemical that plays a role in the production,
refining, distribution, and use of energy and is designated as
``critical'' by the Department of Energy (DOE). Once a
substance has been fast tracked through the premanufacture
notice (PMN) process, the substance could be used for non-
energy applications that could pose unreasonable risks to
health and the environment.
It is unclear how the Secretary would deem a new chemical,
that has not yet entered commerce, to be ``essential'' to an
existing energy sector or system, given that those systems
would presumably continue operating in the absence of the
availability of the new chemical. Also, the supply chain
vulnerabilities of a new chemical would presumably be unclear
since again the chemical has yet to enter the market.
Additionally, there are significant logistical concerns
regarding these provisions--including how EPA and DOE would
share confidential business information and whether DOE's
determination of ``critical energy resources'' would occur
during or before the 90-day review period--all of which
undermine Committee Republican's argument that this legislation
would expedite reviews.
During the Full Committee markup of H.R. 1158, Democratic
Members offered amendments intended to address the problems in
the bill, and concerns voiced by the bill's proponents. Every
Republican Committee member voted against an amendment
excluding perfluoroalkyl and polyfluoroalkyl substances (also
known as PFAS chemicals) from as the definition of a ``critical
energy resource''. PFAS chemicals are known as ``forever
chemicals'' because of their persistence in the environment and
the body. These chemicals have been linked to serious health
problems at low doses, including cancer, hormone disruption,
liver and thyroid problems, interference with vaccine uptake,
reproductive harm, and abnormal fetal development. EPA should
thoroughly review any new PFAS chemicals to ensure they are
manufactured and used in a way that does not pose unreasonable
risk. Safety determinations should be conducted based on
science, not economic considerations, and, considering the
persistent nature of these chemicals, EPA should make an
affirmative determination before they enter commerce and
potentially expose families, workers, and other susceptible
subpopulations.
Every Republican Committee member also voted against an
amendment requiring the U.S. Government Accountability Office
(GAO) to certify that EPA has completed a strategic workforce
plan to support chemical reviews.\3\ While Committee
Republicans have expressed concern about the delays in chemical
reviews, GAO reported that EPA's Office of Chemical Safety and
Pollution Prevention has been under resourced and understaffed
while conducting increased workload at the direction of
Congress. The Biden Administration has requested additional
resources for the Office.\4\ Additionally, EPA has proposed an
updated user fee rule to support chemical reviews and is using
its authority to hire staff with relevant expertise. Congress
should fully fund the TSCA program to provide staff and
resources necessary to safely, transparently, and quickly
review new chemicals proposed for entry into the market.
---------------------------------------------------------------------------
\3\Government Accountability Office, EPA Chemical Reviews:
Workforce Planning Gaps Contributed to Missed Deadlines (Feb. 17, 2023)
(GAO-23-105728).
\4\Environmental Protection Agency, Office of the Chief Financial
Officer, FY 2023 EPA Budget in Brief (Mar. 2023) (EPA-190-R-23-002).
---------------------------------------------------------------------------
CONCLUSION
H.R. 1158 undermines the protections found in TSCA, as
updated by the Lautenberg Act, and puts human health and the
environment at risk. Proponents assert that H.R. 1158 is needed
to expedite chemical reviews essential to the energy sector.
But the majority is positing a false choice. There is no
evidence the public needs to sacrifice health protections from
toxic chemicals in exchange for a clean energy future. The
public needs and wants more, not less, protection from toxic
chemicals.\5\ Undermining the protections in TSCA is not the
answer to fostering innovation. Furthermore, H.R. 1158's
rejection of a future that is clean and health-protective,
sells American innovation short. H.R. 1158 puts workers and
families at risk by rolling back critical public health
protections and weakening a core environmental law.
---------------------------------------------------------------------------
\5\University of California San Francisco Program on Reproductive
Health and the Environment, Public Opinion on Chemicals (prhe.ucsf.edu/
public-opinion-chemicals) (accessed Mar. 16, 2023).
---------------------------------------------------------------------------
For the reasons stated above, we dissent from the views
contained in the Committee's report.
Frank Pallone, Jr.,
Ranking Member, Committee on Energy and Commerce.
[all]